Accordingly, BDNF and GDNF have been identified as potential therapeutic targets in neurodegenerative diseases, and pre-clinical studies have reported the beneficial effects of the administration of BDNF and GDNF in PD models [154,155,156,157,158]. This evidence concerns the gene BDNF and Parkinson disease.